HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mads Bank Lynggaard Selected Research

Therapeutics

11/2022Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mads Bank Lynggaard Research Topics

Disease

1COVID-19
11/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2022

Drug/Important Bio-Agent (IBA)

1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2022
1Angiotensin Receptor AntagonistsIBA
11/2022

Therapy/Procedure

1Therapeutics
11/2022